CXCR2 signaling might have a tumor-suppressive role in patients with cholangiocarcinoma. Yamamoto Y, Sugimoto A, Maruo K, Tsujio G, et al. PLoS One 2022;17:e0266027.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yamamoto Y, Sugimoto A, Maruo K, Tsujio G, et al. CXCR2 signaling might have a tumor-suppressive role in patients with cholangiocarcinoma. PLoS One 2022;17:e0266027.
PMID: 35377900